Trial intelligence / Profile preview

High Dose Chemotherapy With Stem Cell Rescue in Advanced Ovarian Cancer

NCT00003413Phase 2Completed

Sponsor
University of Maryland, Baltimore
Start
Sep 1998
Primary completion
Feb 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of carmustine, melphalan, paclitaxel, cisplatin in ovarian cancer, sponsored by University of Maryland, Baltimore. Started Sep 1998; status: completed.

02

Drugs

carmustinemelphalanpaclitaxelcisplatin
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on NCT00003413.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003413.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call